K. Matsuura

Activated Akt expression has significant correlation with EGFR and TGF-alpha expressions in stage I NSCLC.

T. Mukohara, S. Fukushima, H. Wanibuchi, 2004, Anticancer research.

Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease.

K. Matsuura, Yoshitaka Tateishi, M. Mori, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Monitoring of chemotherapy response in multiple disseminated malignant pleural mesothelioma using fluorodeoxyglucose positron emission tomography

K. Hirata, S. Kudoh, J. Yoshikawa, 2005 .

Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations.

S. Kudoh, K. Hirata, K. Matsuura, 2013, Osaka city medical journal.

C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin

S. Kudoh, K. Hirata, K. Matsuura, 2013 .

EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib.

M. Fukuoka, S. Kudoh, K. Hirata, 2006, Lung cancer.

Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs

S. Kudoh, K. Hirata, K. Matsuura, 2013, BMC Research Notes.

Reaction of plasma adiponectin level in non-small cell lung cancer patients treated with EGFR-TKIs.

S. Kudoh, K. Hirata, K. Matsuura, 2013, Osaka city medical journal.

Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR

A. Kubo, S. Kudoh, K. Hirata, 2016, Expert opinion on pharmacotherapy.

Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer

S. Kudoh, K. Hirata, K. Matsuura, 2012, BMC Cancer.

Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study

S. Kudoh, K. Hirata, K. Matsuura, 2014, BMC Pharmacology and Toxicology.

Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs

S. Kudoh, K. Hirata, K. Matsuura, 2013, BMC Research Notes.